Platinum-Sensitive Ovarian Carcinoma — Trials

Platinum-Sensitive Ovarian Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

26 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 15
Recruiting: 7
Ph III recruiting: 2
Growth YoY: —
Industry share: 33%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04457089	Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer	completed	Early Phase 1	18	Marc GoodmanOTHER	1	Feb 4, 2026	clinicaltrials
NCT05002868	Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors	completed	Phase 1	23	Rhizen Pharmaceuticals SAINDUSTRY	2	Sep 19, 2024	clinicaltrials